Sun Pharma Awards

Sun Pharma/SID Mid-Career Investigator Awards are intended to bridge funding gaps for outstanding mid-career investigative dermatologists.

These awards debuted in 2018, and the number of strong applications exceeded available funding.

Based on a generous grant from Sun Pharma, there will be up to two Bridge Awards of $75,000 each given in 2021 to deserving mid-career investigators in the field of dermatology or cutaneous biology.

Awards are for a period of one year with an option for one renewal.

At least one physician scientist and one PhD cutaneous biologist will be funded.

Active SID Members who are an MD, DO, PhD, MD/PhD or equivalent, and holding a full-time faculty position at a US Department or Division of Dermatology or equivalent.

Applicant must be mid-career and not qualify as an NIH-defined New Investigator.

Applicant must have previously received NIH R01 funding. Prior Ks and R03s are not eligible.

Applicant must have submitted an NIH R01 within the past 12-months that will not be funded by April 2021. Priority will be given to applications with scores that were close to a fundable score for each particular grant mechanism.

Applicant must not have current research support of more than $100,000 available to their lab after April 30, 2021.

Only applications focused on basic or clinical research seeking new discoveries in the field of dermatology or cutaneous biology will be eligible.

An independent SID Grant Review Committee will select award recipients.